Celularity Inc
(CELU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120 | 863 | 293 | 738 | 133 |
| Receivables | 6,705 | 11,152 | 14,968 | 13,557 | 8,770 |
| Inventories | 2,563 | 4,410 | 6,197 | 5,409 | 3,963 |
| TOTAL | $10,596 | $17,263 | $22,080 | $20,561 | $14,502 |
| Non-Current Assets | |||||
| PPE Net | 57,224 | 58,672 | 60,134 | 61,600 | 63,208 |
| Investments And Advances | 2,890 | 0 | 0 | 0 | 0 |
| Intangibles | 15,479 | 15,855 | 16,227 | 16,595 | 16,971 |
| Other Non-Current Assets | 28,050 | 28,493 | 30,435 | 33,926 | 34,159 |
| TOTAL | $103,643 | $103,020 | $106,796 | $112,121 | $114,338 |
| Total Assets | $114,239 | $120,283 | $128,876 | $132,682 | $128,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,722 | 6,945 | 6,653 | 6,361 | 42,610 |
| Accounts payable and accrued liabilities | 24,587 | 24,400 | 23,313 | 23,296 | 15,400 |
| Accrued Expenses | 29,421 | 33,369 | 25,248 | 19,842 | 14,466 |
| Other current liabilities | N/A | 1,010 | N/A | 650 | N/A |
| TOTAL | $65,314 | $69,227 | $58,690 | $53,680 | $76,169 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,234 | 36,492 | 36,492 | 35,927 | N/A |
| Deferred Revenues | 5,584 | 3,503 | 3,476 | 3,531 | 3,693 |
| Other Non-Current Liabilities | 32,012 | 37,183 | 36,387 | 31,505 | 32,743 |
| TOTAL | $69,019 | $76,553 | $75,692 | $70,165 | $35,391 |
| Total Liabilities | $134,333 | $145,780 | $134,382 | $123,845 | $111,560 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,329 | 26,691 | 26,691 | 23,949 | 22,484 |
| Common Shares | 3 | 2 | 2 | 2 | 2 |
| Retained earnings | -967,101 | -944,025 | -919,501 | -899,683 | -886,390 |
| Other shareholders' equity | 0 | -3 | 0 | -5 | -2 |
| TOTAL | $-20,094 | $-25,497 | $-5,506 | $8,837 | $17,280 |
| Total Liabilities And Equity | $114,239 | $120,283 | $128,876 | $132,682 | $128,840 |